Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence.

Gastrointestinal promotility agents may improve tolerance to enteral nutrition, reduce gastroesophageal reflux and pulmonary aspiration, and therefore have the potential to improve outcomes of critically ill patients.